Zobrazeno 1 - 10
of 100
pro vyhledávání: '"N. V. Zhukov"'
Publikováno v:
Онкогематология, Vol 0, Iss 1-2, Pp 86-96 (2022)
High-dose chemotherapy (HDC) with autologous or allogenic hemopoietic stem cell transplantation (SCT) is successfully used in refractory, relapsed or high-risk primary aggressive non-Hodgkin's lymphomas (NHL). Results on HDC employing in follicular l
Externí odkaz:
https://doaj.org/article/6f125326694147cb94304187ce37dd65
Autor:
N. V. Zhukov
Publikováno v:
Онкогематология, Vol 0, Iss 2, Pp 40-46 (2022)
Case report of severe anemia of unknown origin and delayed intravascular hemolysis of transfused blood products in 27 years old female patient with stage IV gastric adenocarcinoma. Article presented diagnostic process with mistakes analysis and liter
Externí odkaz:
https://doaj.org/article/164925ea71d24c758933b1dca9a5f6dc
Autor:
N. V. Zhukov
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 69-76 (2022)
The paper deals with the treatment policy, including erythropoiesis-stimulating drugs (ESD), in anemic patients with malignancies. The use of ESD remains the basic recommended treatment option for anemia in cancer patients treated with cytostatics if
Externí odkaz:
https://doaj.org/article/6c44e8dc7c044a0b8406de8ff7ebca3f
Publikováno v:
Онкогематология, Vol 0, Iss 4, Pp 11-16 (2022)
Treatment results in a group of patients with multiple myeloma (n=18) treated with melfalan (200 mg/m2) followed by autologous peripheral blood stem cell transplantation as a second-line therapy are presented. Thirteen patients received one course of
Externí odkaz:
https://doaj.org/article/c64ef0ba59af417a864c050ffaaa530e
Autor:
N. V. Zhukov
Publikováno v:
Онкогематология, Vol 0, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/f3eb1b4b199845a893e2c2ada2b34ad8
Autor:
N. V. Zhukov
Publikováno v:
Онкогематология, Vol 0, Iss 4, Pp 59-60 (2022)
Externí odkaz:
https://doaj.org/article/a9f781712b2743088df39f29e1c099ac
Autor:
N. V. Zhukov
Publikováno v:
Онкогематология, Vol 11, Iss 2, Pp 52-59 (2016)
In the era of evidence-based medicine the main reason for the implementation of new treatment methods are the results of clinical trials. However, clinical trials is a separate area of knowledge, which is often little known to clinicians, that does n
Externí odkaz:
https://doaj.org/article/e78828ba24414114a3e8f43dfd24dcef
Publikováno v:
Онкогематология, Vol 10, Iss 2, Pp 37-45 (2015)
Neutropenia and associated infection, resulting in hospitalization and use of antibiotics, has a negative effect on chemotherapy. The need to reduce the dose of cytotoxic drugs during neutropenia leads to lower survival rates in patients with hematol
Externí odkaz:
https://doaj.org/article/e6309fd445814f1f87d68647a6043428
Autor:
G. A. Melnichenko, I. S. Stilidi, . ., B. Ya. Alexeev, D. G. Beltsevich, A. O. Raykhman, N. S. Kuznetsov, N. V. Zhukov, V. Yu. Bokhyan
Publikováno v:
Медицинский вестник Юга России, Vol 0, Iss 1, Pp 4-20 (2015)
Statement of hormonal activity and potential malignancy are the most important issues of diagnosis and selection of appropriate treatment way for patients with adrenal tumors. Adrenal cortical carcinoma (ACC) is rare disease with poor prognosis. Inci
Externí odkaz:
https://doaj.org/article/baca0efbdca14969bd24eae4e0bc4123
Publikováno v:
Онкогематология, Vol 9, Iss 4, Pp 54-66 (2015)
The appearance of anticancer drugs dramatically changed cancer treatment, allowing patients with a number of previously fatal diseases to achieve cure and prolong life in patients with incurable tumors. More than 100 anticancer drugs registered to da
Externí odkaz:
https://doaj.org/article/abf1ca2b01a3439ead492600f1c496e4